ArticleClinical kidney journal2015
Challenges and opportunities in late-stage chronic kidney disease.
Article in Clinical kidney journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.
- Pseudohyperphosphatemia in Multiple Myeloma: A Systematic Review of Case Reports and Case Series.Journal of clinical laboratory analysis · 2026Pooled it
- Rationale, design and baseline characteristics of a randomised controlled trial of Interventions to support Patient Activation for adults on hemoDialysis: the IPAD study protocol.BMC nephrology · 2026Article
- Prevalence and predictors of decisional conflict among older African Americans with advanced chronic kidney disease.Innovation in aging · 2026Article
- Predicting kidney replacement therapy, cardiovascular disease and all-cause mortality in advanced chronic kidney disease among the Chinese population.Renal failure · 2025Article
- Factors Affecting Cypriot Nurses' Roles in the Care and Education of Patients with CKD: An Interpretive Phenomenological Study.Healthcare (Basel, Switzerland) · 2025Article
- Prevalence and varieties of complementary and alternative medicine usage among individuals with pre-dialysis chronic kidney disease in Taiwan: an investigative cross-sectional analysis.BMC complementary medicine and therapies · 2024Article
- Associations of COVID-19-related fear with kidney disease quality of life and its subscales among hemodialysis patients as modified by health literacy: a multi-hospital survey.Health psychology and behavioral medicine · 2024Article
- Navigating the Crossroads: Understanding the Link Between Chronic Kidney Disease and Cardiovascular Health.Cureus · 2023Review
- Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.Medicina (Kaunas, Lithuania) · 2023Review
- Applying A Biopsychosocial Framework to Achieve Durable Behavior Change in Kidney Disease.Seminars in nephrology · 2021Review
- Unmet needs for CKD care: from the general population to the CKD clinics-how many patients are we missing?Clinical kidney journal · 2021Article
- Fecal Metabolomics Reveals Distinct Profiles of Kidney Transplant Recipients and Healthy Controls.Diagnostics (Basel, Switzerland) · 2021Article
- Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery.Journal of the American Society of Nephrology : JASN · 2020Review
- Article
- Socioeconomic Determinants of Knowledge of Kidney Disease Among Residents in Nigerian Communities in Lagos State, Nigeria.Oman medical journal · 2019Article
- Validation of the Rainbow Model of Integrated Care Measurement Tools (RMIC-MTs) in renal care for patient and care providers.PloS one · 2019Article
- Article
- Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases.Kidney international reports · 2017Article
- Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study.BMC nephrology · 2017Article
- Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1.Frontiers in medicine · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is increasing recognition that chronic diseases are a major challenge for health delivery systems and treasuries. These are highly prevalent and costly diseases and frequency is expected to increase greatly as the population of many countries ages. Chronic kidney disease (CKD) has not received the same attention as other chronic diseases such as congestive heart failure; yet, the prevalence and costs of CKD are substantial. Greater recognition and support for CKD may require that the disease no longer be viewed as one continuous disease state. Early CKD stages require less complex care and generate lower costs. In contrast, late-stage CKD is every bit as complex and costly as other major chronic diseases. Health authorities may not recognize and fund CKD care appropriately until late-stage CKD is defined clearly as separate and distinct from earlier stages of disease. In this review, we describe the burden of chronic diseases, consider the challenges and barriers and propose processes to improve late-stage CKD care. In particular, we recommend the need for improved continuity of care, enhanced use of information technology, multidisciplinary care, timely referral to nephrologists, protocol use and improved patient engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.